ID   BMX_HUMAN               Reviewed;         675 AA.
AC   P51813; A6NIH9; O60564; Q12871;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-NOV-2010, entry version 112.
DE   RecName: Full=Cytoplasmic tyrosine-protein kinase BMX;
DE            EC=2.7.10.2;
DE   AltName: Full=Bone marrow tyrosine kinase gene in chromosome X protein;
DE   AltName: Full=Epithelial and endothelial tyrosine kinase;
DE            Short=ETK;
DE   AltName: Full=NTK38;
GN   Name=BMX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RX   MEDLINE=95060827; PubMed=7970727;
RA   Tamagnone L., Lahtinen I., Mustonen T., Virtaneva K., Francis F.,
RA   Muscatelli F., Alitalo R.P., Smith C.I., Larsson C., Alitalo K.;
RT   "BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK
RT   family located in chromosome Xp22.2.";
RL   Oncogene 9:3683-3688(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INDUCTION.
RC   TISSUE=Prostate;
RX   MEDLINE=98188256; PubMed=9520419; DOI=10.1073/pnas.95.7.3644;
RA   Qiu Y., Robinson D., Pretlow T., Kung H.-J.;
RT   "Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an
RT   effector of phosphatidylinositol 3'-kinase and is involved in
RT   interleukin 6-induced neuroendocrine differentiation of prostate
RT   cancer cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3644-3649(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 207-220 AND 223-236, AND PHOSPHORYLATION AT
RP   TYR-216 AND TYR-224.
RX   PubMed=12573241; DOI=10.1016/S1570-9639(02)00524-1;
RA   Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,
RA   Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.;
RT   "Identification of phosphorylation sites within the SH3 domains of Tec
RT   family tyrosine kinases.";
RL   Biochim. Biophys. Acta 1645:123-132(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 536-599.
RC   TISSUE=Blood;
RA   Fuortes M.;
RL   Thesis (1994), Cornell University, United States.
RN   [8]
RP   INTERACTION WITH RUFY1 AND RUFY2.
RX   MEDLINE=22162419; PubMed=11877430; DOI=10.1074/jbc.M111933200;
RA   Yang J., Kim O., Wu J., Qiu Y.;
RT   "Interaction between tyrosine kinase Etk and a RUN-domain and FYVE-
RT   domain containing protein RUFY1. A possible role of Etk in regulation
RT   of vesicle trafficking.";
RL   J. Biol. Chem. 277:30219-30226(2002).
RN   [9]
RP   STRUCTURE BY NMR OF 112-393.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the human BMX SH2 domain and of the BTK motif
RT   of human cytoplasmic tyrosine-protein kinase BMX.";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-284 AND TRP-670.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Activity is required for interleukin 6 (IL-6) induced
CC       differentiation. May play a role in the growth and differentiation
CC       of hematopoietic cells. May be involved in signal transduction in
CC       endocardial and arterial endothelial cells.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- COFACTOR: Binds 1 zinc ion per subunit (By similarity).
CC   -!- SUBUNIT: Interacts with RUFY1 and RUFY2.
CC   -!- INTERACTION:
CC       P46108:CRK; NbExp=1; IntAct=EBI-696657, EBI-886;
CC       P11309:PIM1; NbExp=2; IntAct=EBI-696657, EBI-696621;
CC       P04637:TP53; NbExp=1; IntAct=EBI-696657, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Probable).
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in epithelial and
CC       endothelial cells.
CC   -!- INDUCTION: Activated by IL6/interleukin-6 through
CC       phosphatidylinositol 3-kinase (PI3-kinase) pathway. It is likely
CC       that activation occurs through binding of phosphoinositides to the
CC       PH domain.
CC   -!- DOMAIN: SH2 domain mediates interaction with RUFY1.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily.
CC   -!- SIMILARITY: Contains 1 Btk-type zinc finger.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC08966.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X83107; CAA58169.1; -; mRNA.
DR   EMBL; AF045459; AAC08966.1; ALT_INIT; mRNA.
DR   EMBL; AC097625; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471074; EAW98889.1; -; Genomic_DNA.
DR   EMBL; BC016652; AAH16652.1; -; mRNA.
DR   EMBL; U08341; AAA17744.1; -; mRNA.
DR   IPI; IPI00020899; -.
DR   PIR; S60612; S60612.
DR   RefSeq; NP_001712.1; -.
DR   RefSeq; NP_975010.1; -.
DR   UniGene; Hs.495731; -.
DR   PDB; 2EKX; NMR; -; A=291-393.
DR   PDB; 2YS2; NMR; -; A=113-149.
DR   PDBsum; 2EKX; -.
DR   PDBsum; 2YS2; -.
DR   ProteinModelPortal; P51813; -.
DR   SMR; P51813; 1-111, 5-147, 415-666.
DR   IntAct; P51813; 13.
DR   MINT; MINT-1433284; -.
DR   STRING; P51813; -.
DR   PhosphoSite; P51813; -.
DR   PRIDE; P51813; -.
DR   Ensembl; ENST00000342014; ENSP00000340082; ENSG00000102010.
DR   Ensembl; ENST00000348343; ENSP00000308774; ENSG00000102010.
DR   Ensembl; ENST00000357607; ENSP00000350224; ENSG00000102010.
DR   GeneID; 660; -.
DR   KEGG; hsa:660; -.
DR   UCSC; uc004cww.1; human.
DR   CTD; 660; -.
DR   GeneCards; GC0XP015392; -.
DR   H-InvDB; HIX0016669; -.
DR   HGNC; HGNC:1079; BMX.
DR   HPA; CAB032495; -.
DR   HPA; HPA001048; -.
DR   MIM; 300101; gene.
DR   PharmGKB; PA25389; -.
DR   eggNOG; prNOG13898; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P51813; -.
DR   OMA; WHELPEK; -.
DR   OrthoDB; EOG9M0HKZ; -.
DR   PhylomeDB; P51813; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; angiopoietinreceptor_pathway; Angiopoietin receptor Tie2-mediated signaling.
DR   Reactome; REACT_578; Apoptosis.
DR   NextBio; 2684; -.
DR   PMAP-CutDB; P51813; -.
DR   ArrayExpress; P51813; -.
DR   Bgee; P51813; -.
DR   CleanEx; HS_BMX; -.
DR   Genevestigator; P51813; -.
DR   GermOnline; ENSG00000102010; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0007498; P:mesoderm development; TAS:ProtInc.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_type.
DR   InterPro; IPR001849; Pleckstrin_homology.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR020753; Tyr_kinase_non-rcpt_Btk.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 1.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF262; Tyr_kinase_non-rcpt_Btk; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00402; TECBTKDOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Kinase; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; SH2 domain; Transferase;
KW   Tyrosine-protein kinase; Zinc; Zinc-finger.
FT   CHAIN         1    675       Cytoplasmic tyrosine-protein kinase BMX.
FT                                /FTId=PRO_0000088063.
FT   DOMAIN        4    111       PH.
FT   DOMAIN      296    392       SH2.
FT   DOMAIN      417    675       Protein kinase.
FT   ZN_FING     113    149       Btk-type.
FT   NP_BIND     423    431       ATP (By similarity).
FT   COMPBIAS    251    255       Poly-Ser.
FT   COMPBIAS    282    285       Poly-Ser.
FT   COMPBIAS    286    289       Poly-Glu.
FT   ACT_SITE    536    536       Proton acceptor (By similarity).
FT   METAL       121    121       Zinc (By similarity).
FT   METAL       132    132       Zinc (By similarity).
FT   METAL       133    133       Zinc (By similarity).
FT   METAL       143    143       Zinc (By similarity).
FT   BINDING     445    445       ATP (By similarity).
FT   MOD_RES     216    216       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     224    224       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     566    566       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   VARIANT     284    284       S -> L (in dbSNP:rs35353387).
FT                                /FTId=VAR_041674.
FT   VARIANT     670    670       R -> W (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041675.
FT   CONFLICT    207    207       P -> G (in Ref. 6; AA sequence).
FT   CONFLICT    597    597       A -> S (in Ref. 7; AAA17744).
FT   STRAND      129    133
FT   STRAND      136    139
FT   STRAND      294    297
FT   HELIX       303    312
FT   STRAND      318    323
FT   STRAND      330    334
FT   STRAND      347    350
FT   STRAND      359    362
FT   HELIX       370    379
FT   STRAND      383    385
SQ   SEQUENCE   675 AA;  78011 MW;  CB22382A3BD02599 CRC64;
     MDTKSILEEL LLKRSQQKKK MSPNNYKERL FVLTKTNLSY YEYDKMKRGS RKGSIEIKKI
     RCVEKVNLEE QTPVERQYPF QIVYKDGLLY VYASNEESRS QWLKALQKEI RGNPHLLVKY
     HSGFFVDGKF LCCQQSCKAA PGCTLWEAYA NLHTAVNEEK HRVPTFPDRV LKIPRAVPVL
     KMDAPSSSTT LAQYDNESKK NYGSQPPSSS TSLAQYDSNS KKIYGSQPNF NMQYIPREDF
     PDWWQVRKLK SSSSSEDVAS SNQKERNVNH TTSKISWEFP ESSSSEEEEN LDDYDWFAGN
     ISRSQSEQLL RQKGKEGAFM VRNSSQVGMY TVSLFSKAVN DKKGTVKHYH VHTNAENKLY
     LAENYCFDSI PKLIHYHQHN SAGMITRLRH PVSTKANKVP DSVSLGNGIW ELKREEITLL
     KELGSGQFGV VQLGKWKGQY DVAVKMIKEG SMSEDEFFQE AQTMMKLSHP KLVKFYGVCS
     KEYPIYIVTE YISNGCLLNY LRSHGKGLEP SQLLEMCYDV CEGMAFLESH QFIHRDLAAR
     NCLVDRDLCV KVSDFGMTRY VLDDQYVSSV GTKFPVKWSA PEVFHYFKYS SKSDVWAFGI
     LMWEVFSLGK QPYDLYDNSQ VVLKVSQGHR LYRPHLASDT IYQIMYSCWH ELPEKRPTFQ
     QLLSSIEPLR EKDKH
//
